Michael E. Faerm
Chief Financial Officer at AtaiBeckley Inc. (ATAI)
Michael E. Faerm has filed 3 insider reports with the SEC since May 2024, as chief Financial Officer at AtaiBeckley Inc. (ATAI) and chief Financial Officer at Viracta Therapeutics, Inc. (VIRX). The latest filing, on September 11, 2026, reports sale back to the company at AtaiBeckley Inc. (ATAI).
- Filings
- 3
- Companies
- 2
- Bought on market
- None
- Sold on market
- None
Companies where Michael E. Faerm is an insider
| Company | Role | Shares held | Bought | Sold | Avg buy | Price now | Last filing |
|---|---|---|---|---|---|---|---|
| ATAI AtaiBeckley Inc. | Chief Financial Officer | Sep 11, 2026 | |||||
| VIRX Viracta Therapeutics, Inc. | Chief Financial Officersince May 2024 | May 16, 2024 |
Shares held: common shares owned directly after the latest filing that states it. Avg buy: open-market purchase dollars divided by shares bought, every filing on record.
Every filing
- Sep 11, 2026ATAISEC Form 4 filed by Chief Financial Officer Faerm Michael E. to cover taxesForm 4Sale back to the company
- May 14, 2024VIRXSEC Form 4 filed by Faerm Michael E.Form 4Grant or award
- May 13, 2024VIRXMichael E. Faerm became an insiderForm 3New insider
Compare Michael E. Faerm with
- Michael E. Faerm vs Kevin James Craig1 shared
- Michael E. Faerm vs Gerd Kochendoerfer1 shared
- Michael E. Faerm vs Barrett Christopher Ryan Cave1 shared
- Michael E. Faerm vs Glenn Frank Short1 shared
- Michael E. Faerm vs John Francis Hoffman1 shared
- Michael E. Faerm vs Anne Nagengast Johnson1 shared
Other insiders at the same companies
- Gerd KochendoerferATAI
- Kevin James CraigATAI
- Robert HershbergATAI
- Barrett Christopher Ryan CaveATAI
- Sabrina Martucci JohnsonATAI
- Andrea Heslin SmileyATAI
- Scott BraunsteinATAI
- Laurent FischerATAI
- Christian AngermayerATAI
- John Francis HoffmanATAI
- Anne Nagengast JohnsonATAI
- Srinivas RaoATAI
- Glenn Frank ShortATAI
- Amir H KalaliATAI
- Cosmo Feilding-MellenATAI
- Apeiron Investment Group Ltd.ATAI
Questions about Michael E. Faerm
- What is Michael E. Faerm's role at AtaiBeckley Inc.?
- Michael E. Faerm reports to the SEC as chief Financial Officer at AtaiBeckley Inc. (ATAI), according to the latest filing on September 11, 2026. Michael E. Faerm has also filed as chief Financial Officer at Viracta Therapeutics, Inc. (VIRX).
- Has Michael E. Faerm bought or sold stock recently?
- No open-market purchases or sales by Michael E. Faerm are on file. The filings report sale back to the company and grant or award.
- How do I get alerts when Michael E. Faerm files?
- Follow Michael E. Faerm on Quantisnow and you get an email, and a phone notification on Plus, within minutes of each new Form 4 or Form 5, and of each Form 144 notice of a planned sale. Michael E. Faerm filed 1 time in the last 90 days.
From SEC Forms 3, 4, 5 and 144 filed by Michael E. Faerm (SEC CIK 0001647141). Totals count each trade once, skipping amendments whose original is on file, from May 16, 2024 on. View on SEC EDGAR